It’s not often that a CEO outright dismisses M&A prospects, but Moderna CEO Stéphane Bancel says the mRNA biotech has enough ...

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual ...

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

Moderna, based in Cambridge, will lay off 10% of its workforce and expects “to be fewer than 5,000 colleagues strong” by the ...

OpenAI claims supremacy across coding, agentic skills and nuanced context, to name a a few. Perhaps ironic in this moment, a ...

Vaccine manufacturer Moderna will lay off hundreds of employees about five years after it rose to prominence during the COVID ...

Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...

Moderna's CEO, Stéphane Bancel, stated that vaccination is an "important tool for protecting our youngest against severe disease and hospitalization." ...

Moderna’s CEO Stéphane Bancel celebrated the approval, writing, “COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions.

“COVID-19 continues to pose a significant potential threat to children, especially those with underlying medical conditions. Vaccination can be an important tool for protecting our youngest against ...